Exposure to “forever chemicals,” per- and polyfluoroalkyl substances (PFAS), has been linked to serious health issues, like immune system damage, cancers, pregnancy complications and liver damage. A new study, published in Risk Analysis, finds that the websites people are visiting for PFAS information are leaving them without a lot of the guidance they need to protect themselves. 

A UTMB infectious disease professor says vaccinating cows could reduce H5N1 circulation, limiting spillover to people, and safeguarding poultry.

Paris, France 19-22 May 2026. The Palais de Congrès will once again host EuroPCR, the foremost international Course in interventional cardiovascular medicine whose reputation in education, innovation and sharing experience is the fruit of generations of scientific and clinical practice. Four days during which medical professionals at any level of experience – from fellow to seasoned specialist to allied health professional– will find something of value in this dynamic and unique learning experience that fosters better patient care for all. 

OYE Therapeutics, a clinical-stage biotechnology company developing therapies for perioperative and emergency medicine, announced that the first subject has been dosed in its scientific bridging study evaluating OYE-101. The novel intravenous caffeine formulation is designed to accelerate recovery from general anesthesia and deep sedation.